Medical Management of Psychotropic Side Effects

Aniyizhai Annamalai MBBS, MD Assistant Professor of Psychiatry and of Internal Medicine Yale School of Medicine New Haven, CT, USA

Section I.- Chapter1 Psychotropic prescribing in medically ill patients. -Section II - Metabolic syndrome.- Chapter 2 Obesity.- Chapter 3 Diabetes mellitus and acute hyperglycemia.- Chapter 4 Hypertension and acute hypertensive crisis.- Chapter 5 Hyperlipidemia.- Section III - Cardiovascular system.- Chapter 6 Orthostatic hypotension.- Chapter 7 Tachycardia and myocarditis.- Chapter 8 QTc prolongation.- Chapter 9 Non-QT conduction abnormalities.- Chapter 10 Peripheral edema.- 11 Appendix - miscellaneous electrocardiographic abnormalities.- Section IV - Endocrine system.- Chapter 12 Hyperprolactinemia.- Chapter 13 Thyroid disorders.- Chapter 14 Hypercalcemia.- Section V - Kidney and electrolytes.- Chapter 15 Diabetes insipidus.- Chapter16 Hyponatremia.- Chapter 17 Chronic kidney disease.- Section VI - Genitourinary system.- Chapter 18 Sexual dysfunction.- Chapter 19 Urinary incontinence and retention.- Section VII - Oral and gastrointestinal system.- Chapter 20 Hepatitis.- Chapter 21 Pancreatitis.- 22 Constipation.- 23 Sialorrhea.- 24 Bruxism.- Section VIII - Hematologic system.- 25 Introduction to blood cell disorders.- Chapter 26 Leukopenia.- Chapter 27 Platelet function disorders.- Chapter 28 Thrombocytopenia.- Chapter 29 Anemia.- Chapter 30 Pancytopenia.- Chapter 31 Leukocytosis.- Chapter 32 Eosinophilia.- Section IX - Dermatology.- Chapter 33  Drug-induced cutaneous reactions.- Section X - Neurologic system.- Section X A - Movement disorders.- Chapter 34 Introduction to movement disorders.- Chapter 35 Tremor.- Chapter36 Extrapyramidal symptoms I (Parkinsonism).- Chapter 37  Extrapyramidal symptoms II (Dystonia, akathisia, tardive dyskinesia).- Chapter 38 Tics.- Section X B - Systemic syndromes.- Chapter 39 Myoclonus and serotonin syndrome.- Chapter 40 Creatine kinase elevation and neuroleptic malignant syndrome.- Section X C - Other neurologic conditions.- Chapter 41 Seizures.- Chapter 42 Altered mental status.- Section XI - Others.- Chapter 43 Xerostomia.- Chapter 44 Sedation.- Chapter 45 Priapism.- Chapter 46 Polycystic ovarian syndrome.- Chapter 47 Osteoporosis.- Chapter 48 Drug-induced lupus.- Chapter 49 Cataracts.- Chapter 50 Nephrolithiasis.

"The book is written in simple and concise but at the same time informative enough approach, so that readers get good educational material and coherently structured textbook which addresses various systems-related psychotropic side effects." (Maja Vilibic, Alcoholism and Psychiatry Research, Vol. 54 (01), June, 2018)

"This book covers the common physical health effects of psychotropic medications and how to appropriately diagnose and manage them. ... This is an excellent reference for busy clinicians caring for patients who are prescribed psychotropic medications. ... This book could be a vital reference for providers as it is written in a succinct manner using evidence-based information and itis complete in covering a wide range of topics." (Aaron Plattner, Doody's Book Reviews, June, 2017)